Published • loading... • Updated
MindRank Partners with 3SBio to Commercialize its AI-Designed Oral GLP-1 in China
Summary by The Hamilton Spectator
4 Articles
4 Articles
The Hamilton Spectator+3 Reposted by 3 other sources
MindRank Partners with 3SBio to Commercialize its AI-Designed Oral GLP-1 in China
HANGZHOU, China, Sept. 28, 2026 (GLOBE NEWSWIRE) -- MindRank AI Ltd. ("MindRank") today announced that it has entered into a strategic commercialization agreement with Zhejiang Sunshine Mandi Pharmaceutical Co., Ltd. ("Mandi") and Zhejiang Wansheng Pharmaceutical Co., Ltd. ("Wansheng"), both subsidiaries…
·Hamilton, Canada
Read Full ArticleCoverage Details
Total News Sources4
Leaning Left3Leaning Right1Center0Last UpdatedBias Distribution75% Left
Bias Distribution
- 75% of the sources lean Left
75% Left
L 75%
R 25%
Factuality
To view factuality data please Upgrade to Premium
